These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37694681)
41. Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor. Spissu A; Corsini GU; Marrosu F; Mangoni A Psychopharmacologia; 1975 Nov; 44(3):311-2. PubMed ID: 1208766 [TBL] [Abstract][Full Text] [Related]
42. An experimental model for Huntington's chorea? Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685 [TBL] [Abstract][Full Text] [Related]
46. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048 [TBL] [Abstract][Full Text] [Related]
47. Interventions for fatigue in Parkinson's disease. Elbers RG; Verhoef J; van Wegen EE; Berendse HW; Kwakkel G Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010925. PubMed ID: 26447539 [TBL] [Abstract][Full Text] [Related]
48. Benign hereditary chorea and deletions outside NKX2-1: What's the role of MBIP? Invernizzi F; Zorzi G; Legati A; Coppola G; D'Adamo P; Nardocci N; Garavaglia B; Ghezzi D Eur J Med Genet; 2018 Oct; 61(10):581-584. PubMed ID: 29621620 [TBL] [Abstract][Full Text] [Related]
49. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. ; Frank S; Testa CM; Stamler D; Kayson E; Davis C; Edmondson MC; Kinel S; Leavitt B; Oakes D; O'Neill C; Vaughan C; Goldstein J; Herzog M; Snively V; Whaley J; Wong C; Suter G; Jankovic J; Jimenez-Shahed J; Hunter C; Claassen DO; Roman OC; Sung V; Smith J; Janicki S; Clouse R; Saint-Hilaire M; Hohler A; Turpin D; James RC; Rodriguez R; Rizer K; Anderson KE; Heller H; Carlson A; Criswell S; Racette BA; Revilla FJ; Nucifora F; Margolis RL; Ong M; Mendis T; Mendis N; Singer C; Quesada M; Paulsen JS; Brashers-Krug T; Miller A; Kerr J; Dubinsky RM; Gray C; Factor SA; Sperin E; Molho E; Eglow M; Evans S; Kumar R; Reeves C; Samii A; Chouinard S; Beland M; Scott BL; Hickey PT; Esmail S; Fung WL; Gibbons C; Qi L; Colcher A; Hackmyer C; McGarry A; Klos K; Gudesblatt M; Fafard L; Graffitti L; Schneider DP; Dhall R; Wojcieszek JM; LaFaver K; Duker A; Neefus E; Wilson-Perez H; Shprecher D; Wall P; Blindauer KA; Wheeler L; Boyd JT; Houston E; Farbman ES; Agarwal P; Eberly SW; Watts A; Tariot PN; Feigin A; Evans S; Beck C; Orme C; Edicola J; Christopher E JAMA; 2016 Jul; 316(1):40-50. PubMed ID: 27380342 [TBL] [Abstract][Full Text] [Related]
50. The treatment of the choreas and athetotic dystonias. Godwin-Austen RB J R Coll Physicians Lond; 1979 Jan; 13(1):35-8. PubMed ID: 368331 [No Abstract] [Full Text] [Related]
51. [Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report]. Yokoi K; Kazuta T; Torii R; Endo T; Araki A; Terao S Rinsho Shinkeigaku; 2017 Oct; 57(10):591-594. PubMed ID: 28954970 [TBL] [Abstract][Full Text] [Related]
52. Tetrabenazine treatment for Huntington's disease-associated chorea. Ondo WG; Tintner R; Thomas M; Jankovic J Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001 [TBL] [Abstract][Full Text] [Related]
53. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
54. The long-term effect of tetrabenazine in the management of Huntington disease. Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408 [TBL] [Abstract][Full Text] [Related]
55. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491 [TBL] [Abstract][Full Text] [Related]
56. TITF-1 gene mutation in a case of sporadic non-progressive chorea. Response to levodopa treatment. Fons C; Rizzu P; Garcia-Cazorla A; Martorell L; Ormazabal A; Artuch R; Campistol J; Fernandez-Alvarez E Brain Dev; 2012 Mar; 34(3):255-7. PubMed ID: 21555194 [TBL] [Abstract][Full Text] [Related]
57. Benign hereditary chorea: dopaminergic brain imaging in patients with a novel intronic NKX2.1 gene mutation. Konishi T; Kono S; Fujimoto M; Terada T; Matsushita K; Ouchi Y; Miyajima H J Neurol; 2013 Jan; 260(1):207-13. PubMed ID: 22825795 [TBL] [Abstract][Full Text] [Related]
58. Neurochemical supplementation in patients with depressed levels of participation after brain tumor surgery: Rationale and preliminary results. Briggs RG; Ahsan SA; Conner AK; Nix CE; Jacobs CC; Jones RG; Sheets JR; Palejwala AH; Chendeb K; Sughrue ME J Clin Neurosci; 2020 Jan; 71():93-96. PubMed ID: 31771803 [TBL] [Abstract][Full Text] [Related]
59. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases. Shen V; Clarence-Smith K; Hunter C; Jankovic J Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 24255799 [TBL] [Abstract][Full Text] [Related]
60. Alpha methylparatyrosine and tetrabenazine in movement disorders. Lang AE; Marsden CD Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]